Next Article in Journal
Dismantling Barriers to Hepatitis B and Delta Screening, Prevention, and Linkage to Care among the PWUD Community in Philadelphia
Previous Article in Journal
Detection and Characterization of Influenza A Virus Endemic Circulation in Suckling and Nursery Pigs Originating from Vaccinated Farms in the Same Production System
 
 
Article
Peer-Review Record

Trends in and Risk Factors for Drug Resistance in Mycobacterium tuberculosis in HIV-Infected Patients

Viruses 2024, 16(4), 627; https://doi.org/10.3390/v16040627
by Xiaoqin Le 1, Xueqin Qian 2, Li Liu 1, Jianjun Sun 1, Wei Song 1, Tangkai Qi 1, Zhenyan Wang 1, Yang Tang 1, Shuibao Xu 1, Junyang Yang 1, Jiangrong Wang 1, Jun Chen 1, Renfang Zhang 1, Zhaoqin Zhu 2 and Yinzhong Shen 1,*
Reviewer 2: Anonymous
Viruses 2024, 16(4), 627; https://doi.org/10.3390/v16040627
Submission received: 6 April 2024 / Revised: 15 April 2024 / Accepted: 16 April 2024 / Published: 18 April 2024
(This article belongs to the Section Human Virology and Viral Diseases)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

Autors write an interesting and well present paper 

Below my suggestions:

1. Introduction: add data on Global Tb report on HIV and TB co-infection and worsening condition. In addition, consider also as a risk factor of onset TB MDR the social determinant of health (see and cite Social determinants of therapy failure and multi drug resistance among people with tuberculosis: A review. Tuberculosis (Edinb). 2017 Mar;103:44-51. doi: 10.1016/j.tube.2017.01.002.)

2.Methods : clear and excellent

3. Result: no suggestion, clear table and figure are clear

4. Discussion: please discuss also the role of adverse event and drug drug interaction. Again the role of social determinat of health are relevant in HIV-TB coinfection. Add also limitations section

5. Conclusion: give some global health proposal that came from your good paper

Comments on the Quality of English Language

good english minor mistake are present

Author Response

Response to Reviewers' Comments:

First of all, we are pleased to thank the reviewers for these valuable comments that help us improve the quality of our manuscript.

Reviewer 1

  1. Comments and Suggestions for Authors

Comment 1: Introduction: add data on Global Tb report on HIV and TB co-infection and worsening condition. In addition, consider also as a risk factor of onset TB MDR the social determinant of health (see and cite Social determinants of therapy failure and multi drug resistance among people with tuberculosis: A review. Tuberculosis (Edinb). 2017 Mar; 103:44-51. doi: 10.1016/j.tube.2017.01.002.)

Response: We are very grateful for pointing out the deficiencies of this article and offering improvement approach. In the section of INTRODUCTION, we refreshed the reference of Global tuberculosis report 2023 and added the latest epidemiological data of HIV/TB coinfection (lines 40-50 in the version without tracked changes). As our study did not include the social determinants of health as the risk factors, we consider that it is inappropriate to add related literature in this part of background introduction, but we have added it in the DISCUSSION section.

Comment 2: Methods: clear and excellent

Response: We thank the reviewer for the positive feedback.

Comment 3: Result: no suggestion, clear table and figure are clear

Response: Much thanks for your recognitions of our work.

Comment 4: Discussion: please discuss also the role of adverse event and drug drug interaction. Again the role of social determinat of health are relevant in HIV-TB coinfection. Add also limitations section

Response: Thanks for your constructive suggestions. In the DISCUSSION section in the revised manuscript, we discussed the role of adverse event and drug-drug interaction on impact of acquired drug resistance in lines 288-303 of the version without tracked changes and added the content of social determinant as the potential factors of MDR-TB in lines 306-311. Furthermore, we added the fourth point of the limitations in lines 350-353.

Comment 5: Conclusion: give some global health proposal that came from your good paper

Response: We quite appreciate for your insightful suggestion. In this section of revised paper, we elucidated the meaning of our study and provided several proposals on the management of drug resistance tuberculosis in lines 360-364.

 

  1. Comments on the Quality of English Language

good english minor mistake are present

Response: Thanks quite a lot for your helpful comment. Again, we have checked all the expressions in the manuscript and revised the language errors. 

Reviewer 2 Report

Comments and Suggestions for Authors

Le et al. reported on mycobacterial resistance in Chinese HIV patients. The epidemiological report is short and straightforward, I only have very few minor suggestions.

1. Methods chapter, sub-heading 2.3.) Why did the authors decide against simply using WHO definitions? Please explain more thoroughly, as deviation from WHO standards makes the comparison of your work with other international publications unnecessarily challenging.

2. Discussion, limitations paragraph, line 296) I guess the term “can” is too tough wording here and should be replaced by “might”.

Author Response

Response to Reviewers' Comments:

First of all, we are pleased to thank the reviewers for these valuable comments that help us improve the quality of our manuscript.

Reviewer 2

Comments and Suggestions for Authors

Comment 1: Methods chapter, sub-heading 2.3.) Why did the authors decide against simply using WHO definitions? Please explain more thoroughly, as deviation from WHO standards makes the comparison of your work with other international publications unnecessarily challenging.

Response: We are extremely grateful for your constructive and enlightening suggestions. The biggest difference between the Chinese standards of tuberculosis classification (WS 196-2017) and the latest WHO standards is about the definition of XDR-TB. The reason why we adopted the former standards to define XDR-TB is mainly because phenotype susceptibility testing of linezolid and bedaquiline has not been carried out and the results were unavailable in our hospital. We have made further explanations in the manuscript correspondingly (lines 135-137 in the version without tracked changes). We renewed the references about WHO definitions and changed the sequence of literatures accordingly.

Comment 2: Discussion, limitations paragraph, line 296) I guess the term “can” is too tough wording here and should be replaced by “might”.

Response: Thanks a lot for this meaningful and wise advice. We have replaced the term “can” with “might” in the revised manuscript.

Back to TopTop